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Abstract: Aims: Total haemoglobin mass (tot-Hb) increases during high-altitude acclimatization. Nor-
malization of tot-Hb upon descent is thought to occur via neocytolysis, the selective destruction of newly
formed erythrocytes. Because convincing experimental proof of neocytolysis is lacking, we performed a
prospective study on erythrocyte survival after a stay at the Jungfraujoch Research Station (JFJRS; 3450
m). Methods: Newly formed erythrocytes of 12 male subjects (mean age 23.3 years) were age cohort
labelled in normoxia (110 m) and during a 19-day high-altitude sojourn by ingestion of 13 C2- and 15
N-labelled glycine respectively. Elimination dynamics for erythrocytes produced in normoxia and at high
altitude were measured by isotope ratio mass spectrometry of haem, by determining tot-Hb, reticulocyte
counts, erythrocyte membrane protein 4.1a/4.1b ratio and by mathematical modelling. Results: Tot-Hb
increased by 4.7% ± 2.7% at high altitude and returned to pre-altitude values within 11 days after de-
scent. Elimination of 13 C- (normoxia) and 15 N- (high altitude) labelled erythrocytes was not different.
Erythropoietin levels and counts of CD71-positive reticulocytes decreased rapidly after descent. The
band 4.1a/4.1b ratio decreased at altitude and remained low for 3-4 days after descent and normalized
slowly. There was no indication of haemolysis. Conclusion: We confirm a rapid normalization of tot-Hb
upon descent. Based on the lack of accelerated removal of age cohorts of erythrocytes labelled at high
altitude, on patterns of changes in reticulocyte counts and of the band 4.1a/4.1b ratio and on modelling,
this decrease did not occur via neocytolysis, but by a reduced rate of erythropoiesis along with normal
clearance of senescent erythrocytes.
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Abstract
Aims: Total haemoglobin mass (tot- Hb) increases during high- altitude acclimatiza-
tion. Normalization of tot- Hb upon descent is thought to occur via neocytolysis, the 
selective destruction of newly formed erythrocytes. Because convincing experimen-
tal proof of neocytolysis is lacking, we performed a prospective study on erythrocyte 
survival after a stay at the Jungfraujoch Research Station (JFJRS; 3450 m).
Methods: Newly formed erythrocytes of 12 male subjects (mean age 23.3  years) 
were age cohort labelled in normoxia (110 m) and during a 19- day high- altitude so-
journ by ingestion of 13C2- and 15N- labelled glycine respectively. Elimination dy-
namics for erythrocytes produced in normoxia and at high altitude were measured by 
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1 |  INTRODUCTION
An increased haemoglobin (Hb) concentration and total 
Hb mass (tot- Hb) are typical observations in long- term so-
journers at high altitude and in high- altitude residents.1- 4 It 
is caused by a HIF- 2alpha- driven and erythropoietin (Epo)- 
dependent stimulation of erythropoiesis 5,6 and a decrease in 
plasma volume,1 and boosts the oxygen- carrying capacity of 
blood when the partial pressure of oxygen in inspired air and 
in blood is low. Upon descent from high altitude, EPO levels 
fall, plasma volume increases and, subsequently, Hb concen-
tration and tot- Hb normalize within a few days.
Because of the short time required for the readjustment 
of tot- Hb, it has been claimed that mechanisms other than a 
decrease in the erythropoietic activity must account for the 
decrease in tot- Hb. The low number of reticulocytes was 
taken as evidence for removal, especially, of the young frac-
tion of erythrocytes (neocytes), which resulted in formulating 
the hypothesis of neocytolysis.7 The phenomenon was first 
described in astronauts, where centralization of blood flow 
seems to cause a decrease in Epo levels.8 Other supporting 
evidence was a low reticulocyte count and an altered pattern 
of the decay rate of 51Cr- labelled erythrocytes.8 The hypoth-
esis claims that, particularly in the early phase, the decreased 
Epo triggers the specific removal of young erythrocytes8 
by low Epo- dependent interaction of vascular endothelium 
and macrophages9 because high Epo levels would serve as a 
survival factor not only for erythroid precursors but also for 
circulating young erythrocytes.7 A decreased erythropoietic 
rate was thought to account for low tot- Hb and Hb concen-
trations during continued low Epo levels. The hypothesis of 
neocytolysis was subsequently proposed to explain the anae-
mia of chronic renal failure, where Epo levels are low,10,11 
anaemia of malaria12 and certain congenital haemolytic anae-
mia such as pyruvate kinase deficiency.13 It was also proposed 
that neocytolysis explains the rapid decrease in tot- Hb upon 
descent from high altitude, when elevated Epo levels return 
to normal.7,14- 17 Rice and colleagues14 found that adminis-
tering Epo to three subjects upon descent prevented the loss 
of reticulocytes, indicating that the removal of erythrocytes 
depended on Epo but not on oxygen availability.
In all these reports, the main evidence supporting neocy-
tolysis is a decrease in the reticulocyte count,18,19 but solid 
experimental evidence demonstrating the selective loss of 
neocytes and an evaluation of the role of decreased eryth-
ropoiesis are missing.18,19 Nevertheless, the neocytolysis hy-
pothesis is acknowledged in editorials20 and in haematology 
textbooks.21
The most stringent proof of neocytolysis would require 
demonstration of the clearance of neocytes after a rapid de-
crease in Epo levels subsequent to descent from high alti-
tude after a prolonged sojourn, for example, by following the 
fate of an age cohort of young erythrocytes. This technique 
had been applied but revealed no conclusive results, likely 
because of insufficient labelling intensity.14 It was therefore 
the goal of this study to monitor the survival of age cohorts of 
erythrocytes metabolically labelled with 15N- glycine during 
maturation in the bone marrow at high altitude as well as 
other markers of erythrocyte age upon descent from a 19- 
days stay at an altitude of 3450  m (Jungfraujoch Research 
Station [JFJRS]) in comparison to erythrocytes labelled with 
13C2- glycine in the pre- altitude normoxia period.
isotope ratio mass spectrometry of haem, by determining tot- Hb, reticulocyte counts, 
erythrocyte membrane protein 4.1a/4.1b ratio and by mathematical modelling.
Results: Tot- Hb increased by 4.7% ± 2.7% at high altitude and returned to pre- altitude 
values within 11 days after descent. Elimination of 13C- (normoxia) and 15N- (high 
altitude) labelled erythrocytes was not different. Erythropoietin levels and counts of 
CD71- positive reticulocytes decreased rapidly after descent. The band 4.1a/4.1b ratio 
decreased at altitude and remained low for 3- 4 days after descent and normalized 
slowly. There was no indication of haemolysis.
Conclusion: We confirm a rapid normalization of tot- Hb upon descent. Based on the 
lack of accelerated removal of age cohorts of erythrocytes labelled at high altitude, 
on patterns of changes in reticulocyte counts and of the band 4.1a/4.1b ratio and 
on modelling, this decrease did not occur via neocytolysis, but by a reduced rate of 
erythropoiesis along with normal clearance of senescent erythrocytes.
K E Y W O R D S
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2 |  RESULTS
Age cohort- labelled erythrocytes, total haemoglobin mass 
(tot- Hb), reticulocyte counts and reticulocyte maturity, mark-
ers of erythrocyte age, iron metabolism and markers of hae-
molysis were analysed in 12 healthy male volunteers (age: 
23.3 ± 3.3 years; height: 185 ± 7 cm; weight: 75.8 ± 5.9 kg; 
mean ± SD). Measurements were performed before (in nor-
moxia; white), during a 19- days long sojourn at high alti-
tude (3,450  m a.s.l. at the Jungfraujoch Research Station, 
Switzerland; blue) and after return to sea level (grey; time-
line in Figure 1). Age cohort labelling with glycine, which is 
incorporated metabolically into haem during synthesis, was 
performed by feeding the subjects a bolus of 13C2- glycine 
in the pre- altitude test, and glycine labelled with 15N at high 
altitude 9 days before return to sea level. Rapid disappear-
ance of the 15N- label from the circulation soon after return of 
the subjects to sea level would directly indicate that erythro-
cytes produced and labelled at high altitude are prematurely 
cleared.
Ascent to high altitude shows the expected increase in Epo 
plasma levels above baseline (+53%; P <  .001), which re-
mained elevated at high altitude, although 12% lower on day 
18 than on day 10 (Figure 2A). Epo levels dropped at descent 
from altitude (Figure 2A), and for 1 week remained 50% lower 
than at high altitude (P < .001) and ~30% lower with respect 
to pre- altitude levels (P <  .001). The high altitude- induced 
increase in tot- Hb by 4.7%  ±  2.7% (mean  ±  SD; n  =  12) 
was reversed 11 days after descent (Figure 2B). Plasma vol-
ume was decreased by 18.0% ± 8.1% (P < .001) on day 18 
at the JFJRS compared to pre- altitude, and was still below 
pre- altitude values 11  days after descent (−8.1%  ±  7.9%; 
P  =  .002), but was significantly increased relative to high 
altitude (P < .001).
The increase in the number of short- lived, early reticu-
locytes,22 evaluated as CD71+ and CD235a+, on days 5 
(+23%; P = .037) and 10 (+29%; P = .014) at high altitude 
(Figure 3A) indicates the stimulation of erythropoiesis. Upon 
descent, their counts decreased (day 3: −48% vs high alti-
tude, P = .001; day 5: −54% vs high altitude, P = .001) to 
values even below baseline (day 3 after descent: −40% vs 
pre- altitude; P  <  .003), reflecting suppression of erythro-
poiesis (Figure  3A). The counts of the longer- lived RNA+ 
reticulocytes were increased at high altitude (day 18: +30%; 
P = .001) compared with baseline (Figure 3B). Their number 
was still higher than at baseline on day 3 after the descent 
(+18%; P = .009) but then fell below baseline (day 10 after 
the descent: −26%; P = .003). The change in RNA fluores-
cence intensity (Figure 3C) reflects this differential behaviour 
of CD71+/CD235a+ and RNA+ erythrocytes. It was highest, 
when the release of reticulocytes from the bone marrow was 
highest at the beginning of the stay at high altitude (+53% on 
day 3 P < .001), decreased on day 18 at high altitude (−35%; 
P  <  .001) and even further decreased 3  days after descent 
(−41%; P < .001).
The highest level of age cohort label appeared in blood 
20 to 30  days after glycine intake. However, in contrast to 
the hypothesis, after return to sea level, the survival of the 
age cohort of cells labelled at high altitude (Figure 4A, cir-
cles) followed exactly the curve obtained in the normoxic 
pre- altitude test (Figure  4A, triangles). This result clearly 
demonstrates that the neocytes produced during the stay at 
high altitude have not been removed but were still present 
in circulating blood. This interpretation is supported by a 
mathematical model elaborated to predict the evolution of 
the age cohort label and of other haematological parame-
ters in the presence or absence of neocytolysis after return 
to sea level (see Methods and Supplement for details): The 
F I G U R E  1  Timeline of blood sample collection. Sampling time is colour coded: Sampling during the pre- altitude control study is shown in 
white, high altitude in blue and collection after return from high altitude in grey. This colour coding is also used for the bar charts. Black arrows 
indicate blood collection for the measurement of 13C/12C (pre- altitude, 110 m) and 15N/14N (high altitude, 3540 m, and post- altitude; 110 m) in 
haem. The exact days blood samples were collected after glycine intake for isotope incorporation in the pre- altitude and altitude/post- altitude tests 
are shown in Figure 4A. The volumes of blood collected at each of the indicated time points were: age cohort labelling (black arrows, 2 mL); CO- 
Hb/tot- Hb (brown arrows; 2 × 1.5 mL); reticulocyte and erythrocyte functions (not shown here; orange arrows; 30 mL), protein 4.1R (dark blue 
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model fits the observed survival curve of 15N- labelled eryth-
rocytes very well when no neocytolysis is assumed (black 
line in Figure 4A), whereas it predicts a rapid decline in 15N- 
labelling intensity upon descent if neocytolysis of different 
degrees had occurred (grey lines in Figure 4A).
Additional evidence for the presence of neocytes in the 
circulation rather than neocytolysis came from the analysis 
of protein 4.1R. The 4.1a/4.1b ratio can be considered a ‘mo-
lecular clock’23,24 because non- enzymatic deamidation of 
asparaginyl residues in protein 4.1b, the isoform present in 
erythroblasts, results in 4.1a in a time- dependent manner, and, 
thus, the protein 4.1a/4.1b ratio increases with erythrocyte 
age.23,24 The mean 4.1a/4.1b ratio of circulating erythrocytes 
progressively decreased at high altitude (Figure 4B), reflect-
ing the increasing abundance of young erythrocytes in blood 
with respect to baseline. After descent, the 4.1a/4.1b ratio 
remained low proving the presence in the circulation of the 
neocytes produced at high altitude. The model predicts this 
pattern quite well (black line, Figure 4B) and indicates that 
neocytolysis would result in a rapid increase in the 4.1a/4.1b 
ratio to values higher than pre- altitude within a few days after 
descent because of the removal of erythrocytes high in pro-
tein 4.1b (grey line in Figure 4B).
An increased iron demand associated with the stimula-
tion of erythropoiesis is indicated by the decreased plasma 
ferritin levels on days 10 (−6%) and 18 (−14%) at high al-
titude (P  <  .001) respectively (Table  1). Ferritin was still 
low on day 3 after descent (−28% with respect to baseline; 
P = .002) but then returned to the pre- altitude value. Plasma 
iron levels remained unchanged throughout the study 
(P  =  .079). There was an increase in transferrin levels at 
high altitude (+5%; P = .047; HA- 18), whereas transferrin 
saturation changed little (P = .046). The levels of transferrin 
decreased below the pre- altitude values upon descent (−5%; 
P = .022, post- altitude day 7). There was no change in total, 
direct or indirect bilirubin. Haptoglobin increased at high 
altitude (day 10: +26%, P = .011; day 18: +24%, P = .043) 
(Table 1), and slowly returned to normoxic values upon re-
turn to sea level.
3 |  DISCUSSION
A rapid normalization of tot- Hb has been reported after de-
scent from high altitude.7,14- 16 This could be achieved by a 
reduction of the rate of erythropoiesis or by an increase in 
the rate of removing of circulating erythrocytes. The latter 
has been proposed to occur by the selective elimination of 
newly formed erythrocytes, that is, ‘young’ erythrocytes 
called neocytes.7 Our results confirm the decreases in tot-
 Hb and reticulocyte counts within a few days after descent 
from high altitude, but we did not find indications of hae-
molysis. In addition, we demonstrate for the first time that 
the survival of age cohort- labelled erythrocytes produced 
during a stay at high altitude did not differ from that of 
erythrocytes produced at sea level, and that only the number 
of the very young, CD- 71- positive fraction of reticulocytes 
was decreased but that the older reticulocytes remained in 
circulation. Furthermore, results from modelling strongly 
support the notion that neocytolysis, the selective removal 
of young erythrocytes produced at high altitude, cannot 
explain the observed changes in age cohort- labelled eryth-
rocytes or in markers of erythrocyte age after the descent 
to sea level, but that decreasing the rate of erythropoiesis 
is sufficient to explain the decrease in tot- Hb after descent 
from high altitude.
F I G U R E  2  Changes in Epo levels and tot- Hb during 
acclimatization at high altitude and after return to sea level. A, Box 
plots of plasma levels of Epo measured during the study. B, Mean 
values ± SD of total haemoglobin mass during and after the sojourn at 
high altitude measured by CO rebreathing before ascent (pre), on day 
18 at high altitude (3450 m) and 11 days after descent (post). The black 
line indicates the values of tot- Hb predicted by the mathematical model 
in the absence of neocytolysis. The grey lines indicate that the tot- Hb 
values predicted in case neocytolysis were triggered at four possible 
degrees of intensity, upon return to sea level. A and B, Vertical dashed 
lines indicate the beginning and end of the stay at high altitude. 
*Significantly different from pre- altitude control; #significantly 
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Age cohort labelling is a strong tool to evaluate survival 
of erythrocytes produced in special situations. Preferential re-
moval of the young erythrocytes, which were produced during 
the stay at high altitude, would result in a rapid decrease in 
the number of age cohort- labelled erythrocytes within a 
few days after descent. This can be predicted by modelling 
F I G U R E  3  Changes in reticulocyte 
counts and reticulum- fluorescent intensity 
during acclimatization at high altitude and 
after return to sea level. Box plots of (A) 
reticulocyte counts determined as CD71- 
and CD235a- positive cells, (B) reticulocyte 
counts determined as RNA- positive 
erythrocytes and (C) RNA fluorescence 
intensity in reticulocytes measured by flow 
cytometry. n = 12. A– C, Vertical dashed 
lines indicate the beginning and end of 
the stay at high altitude. *Different from 
pre- altitude control; #altitude day 19 and 
post- altitude values different from values on 
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complete or partial neocytolysis indicated by the grey lines 
in Figure  4A. Since these lines clearly do not fit the data, 
the results in Figure 4A and the individual curves shown in 
Figure S3 indicate that the neocytes produced during the stay 
at high altitude remained in circulation and that their lifespan 
was not truncated in comparison to erythrocytes produced in 
normoxia. Thus, this result does not support the occurrence 
of neocytolysis. Our results contradict a report on a (statisti-
cally not significant) change in age cohort- labelled erythro-
cytes claiming compatibility with neocytolysis.14 However, 
the authors indicate that the labelling intensity may have been 
insufficient.14
Several other parameters evaluated in our study indicated 
the presence of neocytes in circulating blood after descent, 
again pointing to the absence of neocytolysis. The level of 
reticulocytes counted as RNA- positive erythrocytes was 
still elevated on day 3 after descent (Figure  3B). Because 
the elimination of RNA from reticulocytes requires several 
days, this finding indicates that these reticulocytes had not 
been removed rapidly after descent. The 4.1a/4.1b ratio of 
the erythrocyte membrane protein 4.1R strongly depends 
on erythrocyte age.23 It decreased at high altitude because 
of the appearance of reticulocytes and young erythrocytes 
subsequent to a stimulation of erythropoiesis and remained 
low until day 10 after descent (Figure 4B). These decreased 
4.1a/4.1b ratio indicates the persisting presence of the young 
erythrocytes produced at high altitude in the circulation. If 
these cells had undergone neocytolysis, one would expect a 
sharp increase in the 4.1a/4.1b ratio after descent, as indi-
cated by the model (Figure 4B). Together, the results regard-
ing RNA- positive erythrocytes and the band 4.1a/4.1b ratio 
strongly support the notion that the erythrocytes produced at 
high altitude remained in the circulation and did not undergo 
neocytolysis.
The removal of any age cohort of erythrocytes after de-
scent might also cause alterations in parameters indicating 
haemolysis. Increased plasma levels of haem- breakdown 
products and elevated levels of ferritin indicating recircula-
tion of released iron have been reported after a return from 
altitudes >4000  m.14 Decreased haptoglobin levels might 
be an indicator of haemolysis. However, we did not observe 
changes in any of these parameters upon descent that were 
consistent with haemolysis.25
There is of course the possibility that removal of only ~5% 
of the tot- Hb resulted in minute changes that could not be 
detected with those parameters. If there were mild haemoly-
sis, our results would not allow the drawing of conclusions 
regarding the possible mechanisms. A different experimen-
tal setting would be needed to test for the altered expression 
of catalase and increased mitochondrial ROS production by 
reticulocytes, as found in mice,26 and for an Epo- dependent 
interaction of erythrocyte surface adhesion molecules 
F I G U R E  4  Change in age cohort labelling intensity and 
erythrocyte membrane protein 4.1a/4.1b values during acclimatization 
at high altitude and after return to sea level. A, Time course of 13C/12C 
and 15N/14N ratios in haem. For the pre- altitude control study, 13C2- 
labelled glycine was ingested ~6 months prior to the ascent to high 
altitude (intake and all time points in normoxia; white triangles). On 
day 10 at high altitude, 15N- labelled glycine was ingested to label the 
erythrocytes produced during the stay at high altitude (blue circles). 
Descent was on day 9 after 15N- glycine intake (grey circles). Individual 
values for the 13C/12C and 15N/14N ratios are normalized to the mean 
values of delta over baseline (DOB) on days 19- 28 after intake. 
Mean values ± SD, n = 12. Individual curves showing the changes 
in the 13C/12C and 15N/14N ratios are in the Figure S4. The vertical 
dashed line indicates the end of the stay at high altitude (relevant 
for 15N/14N data). The black line shows the change in age cohort 
labelling predicted by the model for a normal erythrocyte lifespan 
(see Methods). Grey lines indicate the predicted change in the 15N/14N 
upon descent if neocytolysis of varying intensity occurred. B, Box 
plots of the 4.1a/4.1b ratio of band 4.1R measured in erythrocyte ghost 
membranes before, during and after the stay at high altitude. n = 12. 
*Different from pre- altitude control, #different from peak value at high 
altitude. The black line indicates the behaviour in the 4.1a/4.1b ratio 
predicted by the model if neocytolysis did not occur. The grey line 
indicates the predicted change if neocytolysis after descent was 100% 
responsible for the change. Vertical dashed lines indicate the beginning 
and the end of the stay at high altitude
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with the endothelium and their subsequent removal by 
macrophages.7,26,27
Because our results do not support the facilitated removal 
of neocytes from the circulation upon descent, that is, neocy-
tolysis, a decreased erythropoiesis rate appears to be the only, 
and perhaps the most intuitive, mechanism that might explain 
the decrease in tot- Hb after descent. While we have no direct 
measure thereof, the post- descent decreases in the number of 
CD71- positive erythrocytes (Figure 3A) and the rapid decline 
in reticulocytes with an elevated RNA content (Figure 3B,C) 
are consistent with this notion. High numbers of both parame-
ters would reflect the presence of very immature reticulocytes 
because of the stimulation of erythropoiesis.22 The assump-
tion of a decreased rate of erythropoiesis is supported by pre-
vious studies showing a decreased rate of 59Fe removal from 
the blood in highlanders after descending from high altitude to 
values well below those in normoxic controls.28
Modelling (details in the supplement) based on our data 
on age cohort labelling and CD71- positive reticulocyte 
counts revealed that a transient decrease in the erythropoiesis 
rate by ~35% would be sufficient to explain the normalization 
of the elevated tot- Hb level within 11 days after descent from 
high altitude, assuming that the rate of removal of senescent 
erythrocytes and the erythrocyte lifespan remained constant. 
The latter assumption is supported by the lack of a difference 
between the 13C/12C and 15N/14N data (Figure 4A). Changes 
in the 4.1a/4.1b ratio estimated with this model showed very 
good agreement with the observed data (Figure 4B), and are 
far from those predicted by the model of a neocytolysis sce-
nario (Figure 4B).
4 |  CONCLUSIONS
Robust data obtained from age cohort labelling of young 
erythrocytes produced at high altitude speak against the se-
lective removal of neocytes, and thus against a process of 
neocytolysis upon return to sea level. Data on changes in re-
ticulocyte counts and of the protein 4.1a/4.1b ratio, which 
serves as a ‘molecular clock’ measuring erythrocyte senes-
cence, corroborate this interpretation. Therefore, the observed 
reduction in tot- Hb after descent from high altitude has to be 
explained by a reduced erythropoietic rate, at a constant rate 
of clearance of senescent erythrocytes, which is supported by 
modelling. Since reducing the erythropoietic rate, and thus 
in tot- Hb, depends on lowering the Epo levels upon descent, 
tot- Hb should also decrease rapidly in equivalent situations, 
such as the cessation of Epo treatment as in renal failure pa-
tients, when athletes return from training at high altitude or 
in patients on long- term oxygen therapy. The time course of 
the decrease in plasma Epo levels and in the total erythrocyte 
mass observed during space flight, the condition under which 
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5 |  METHODS
5.1 | Study design
Subjects were studied before, during and after a 19- day 
sojourn at high altitude (3450  m, Jungfraujoch Research 
Station, Switzerland) to measure changes in total haemo-
globin mass (tot- Hb) by CO rebreathing, erythrocyte lifes-
pan by age cohort labelling, erythropoietin levels, iron status 
and functional parameters characteristic of prematurely se-
nescent erythrocytes that might indicate cell destruction and 
neocytolysis. Pre- and post- altitude measurements were per-
formed in Heidelberg, Germany (110 m; here referred to as 
sea level). The study was approved by the ethics committees 
of the University of Heidelberg, Germany, (S- 066/2018) and 
the University of Bern, Switzerland (2018- 01766) and was 
performed in accordance with the Declaration of Helsinki.
5.2 | Participants
Twelve healthy male subjects (23.3 ± 3.3 years, 185 ± 7 cm, 
75.8 ± 5.9 kg) were recruited by public announcement at the 
University of Heidelberg and participated after providing 
written informed consent. Subjects were physically fit and 
had normal haemoglobin (Hb) concentrations and plasma 
iron status. We chose to study males only to avoid possi-
ble effects of the menstrual cycle on Hb and iron metabo-
lism. Furthermore, the Research Station at the Jungfraujoch 
(JFJRS) accommodates only 12 subjects. Including both 
sexes would have resulted in subgroups that were too small 
for statistical comparison.
5.3 | Procedures
5.3.1 | Time course
The time course of the collection of blood samples is shown 
in Figure 1. The pre- altitude control period started ~6 months 
prior to exposure to high altitude and lasted for 140  days. 
After a 1- month break, pre- altitude measurements of tot- Hb 
were performed. Three days after tot- Hb was measured, the 
subjects travelled to the JFJRS (3450 m) by train. The descent 
and return to Heidelberg were also by train. Subjects did not 
ascend to altitudes above 2000 m during the entire pre- and 
post- altitude study time. For motivational purposes, during 
their stay at the JFJRS, the subjects performed moderately 
intense exercise and hiked to the Mönchsjochhütte (3600 m; 
one way ~30 minutes; weather permitting) several times per 
week. In addition, all subjects participated in weekly walking 
tours that were several hours long accompanied by guides.
During the 19- day period, the subjects were monitored 
clinically with particular emphasis on the development of 
acute mountain sickness (AMS; evaluated by the Lake Louise 
questionnaire and the environmental symptoms question-
naire, ESQ; scores for the quality of sleep were not obtained) 
and received basic clinical examinations. Possible indications 
of high- altitude pulmonary oedema (HAPE) were obtained 
by auscultation and measuring oxygen saturation (SpO2) with 
pulse oximetry (LifeSense II, Nonin). One of the subjects 
showed very mild signs of AMS in the morning of day 2 at 
the JFJRS as indicated by a Lake Louise score of 3 and an 
AMS- C score of 0.7. This was likely caused by a mild airway 
infection indicated by elevated C- reactive protein (CRP) and 
interleukin- 6 (IL- 6) levels. His symptoms normalized within 
the next few days of the stay at the JFJRS without causal 
treatment. None of the other subjects developed symptoms 
of AMS or any illness during the stay at high altitude. This 
was surprising because the literature indicated a prevalence 
of AMS of ~35% at the JFJRS.29,30 There was no evidence 
of HAPE.
5.3.2 | Measurement of the 
erythrocyte lifespan
Age cohort labelling of erythrocytes was performed by the 
ingestion of glycine labelled with non- radioactive, stable iso-
topes. In the pre- altitude test, subjects ingested 2 g of 13C2- 
labelled glycine (CLM- 136- MPT- 0; 99% 13C2; Eurisotop, 
Saint- Aubin, France) dissolved in water and diluted with 
orange juice after a pre- test blood sample (2 mL, K- EDTA 
for anti- coagulation) was collected from an antecubital vein 
using the Sarstedt system. Similarly, 9 days before descend-
ing from the JFJRS, the subjects ingested 2 g of 15N- labelled 
glycine (NLM- 202- MPT- 0; 98% 15N; Eurisotop). The differ-
ent label was chosen to avoid blurring by isotope recycling. 
The days on which blood was drawn for the detection of label 
intensity in circulating erythrocytes are marked in Figures 1 
and 4A.
5.3.3 | Preparation of haem and 
isotope analysis
Haem was prepared from 0.5 mL of frozen erythrocytes ac-
cording to the method described by Ramsey,31 and the 13C/12C 
and 15N/14N ratios were determined according to Browne and 
colleagues using online- combustion and continuous- flow 
isotope ratio mass spectrometry32 calibrated against inter-
national standards. For each participant, the individual delta 
over baseline (DOB) values normalized to the mean value 
of the highest label intensities (days 19 to 28 after glycine 
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intake) allowed the comparison of the 13C/12C and 15N/14N 
curves. Details are provided in the Supplement.
5.3.4 | Total haemoglobin mass
Tot- Hb was measured with a modified version of a carbon 
monoxide (CO) rebreathing technique 33 using an automated 
system (OpCO, Detalo Health, Denmark). The percent car-
boxy- Hb (% CO- Hb) and Hb concentration (Hb) were meas-
ured with a blood gas analyzer (RapidPoint 500, Siemens, 
Germany). The change in the % CO- Hb between the first and 
second measurements was used for the calculation of tot- Hb 
after correction for the amount of CO that remained in the 
rebreathing system.34
5.3.5 | Other measurements
The parameters characterizing iron metabolism (plasma iron 
concentration, ferritin and transferrin), erythropoietin, pa-
rameters indicative of erythrocyte destruction (haptoglobin 
and bilirubin) and inflammation markers (CRP and IL- 6) 
were measured by the Central Laboratory of the University 
Hospital, Heidelberg, Germany.
Early reticulocyte counts were determined by flow cy-
tometry (CyFlow Cube6, Sysmex) from blood collected 
by finger prick, and measurements were performed within 
1 hour. Analysis was performed by counting the cells pos-
itive for staining of the transferrin receptor (CD71- FITC, 
CyFlow, Sysmex) and glycophorin A (CD235a- APC, BD 
Biosciences). Total reticulocyte counts from blood collected 
from an antecubital vein were measured as RNA- positive 
cells (Retic- Count™, BD) by flow cytometry (Gallios Flow 
cytometer, Beckman Coulter Life Sciences).
The ratio of the 4.1a to 4.1b forms of the erythrocyte 
membrane protein band 4.1R was determined as a surrogate 
of changes in mean erythrocyte age because of its strong 
dependence on erythrocyte senescence.23 Contaminating 
leucocytes were removed by filtration, and intensities of the 
doublet of bands 4.1a and 4.1b were measured after the sep-
aration of erythrocyte ghost membrane proteins by sodium 
dodecyl sulphate gel electrophoresis and Coomassie blue 
staining.35
5.4 | Statistical analysis and modelling
The results are shown as box plots and/or as the mean val-
ues  ±  standard deviations. The statistical significance of 
changes in parameters was calculated by one- way analy-
sis of variance for repeated measurements. Pairwise 
multiple- comparison procedures were performed using 
Student– Newman– Keuls tests. Calculations were performed 
with SigmaPlot software (Systat, Germany).
We modelled (details in the Supplement) the temporal 
evolution of tot- Hb, the reticulocyte counts, the 13C/12C and 
15N/14N ratios and the 4.1a/4.1b ratio to estimate the possible 
contribution of neocytolysis. Modelling was performed with 
MATLAB (R2020a; version 9.8.0.1323502; The Mathworks 
Inc, Natick, MA, USA). The data on age cohort labelling were 
used to determine the erythrocyte lifetime distribution based 
on a Weibull distribution.36,37 Changes in the production rate 
of early erythrocytes over time were modelled on the basis 
of the increase in the counts of early reticulocytes shown in 
Figure 3A, that is, a 30% increase upon ascent to high alti-
tude, and a rapid but transient decrease in the erythropoiesis 
rate by ~35% below the pre- altitude rate and a gradual return 
to normal following the pattern of change in CD- 71- positive 
reticulocytes (Figure 3A).
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